Guardant Health is the leading precision oncology company with a dedication to conquering cancer globally. The Company was the first to develop proprietary genomics tests utilizing vast data sets and advanced analytics to find and characterize the basis of cancer in each patient individually. The Company operates through two unique platforms: Oncology and Screening. The Oncology platform generates over $600 million in revenue by improving patient clinical outcomes and lowers healthcare costs across all stages of the cancer care continuum via its unique genomic and epigenomic sequencing capabilities. Oncology products include Guardant360, Guardant360 CDx, Guardant360 TissueNext, Guardant360 Response, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for earlier-stage cancer patients. And within the Oncology platform sits a unique BioPharma services business that has as its clients the world's leading biotech and big pharma companies. The Screening portfolio includes the recently FDA approved next generation sequencing based Shield test to screen the population for Colorectal cancer. This is the only currently approved first line blood test for colorectal cancer. This is a test that will save millions of lives.
Job DescriptionGuardant Health Corporate Development is an elite, small group of individuals within Guardant Health. The group is responsible for license, partnership and acquisition strategy development and execution, long range planning / strategy, and business intelligence insights. The group operates through advisement to the Guardant Health Investment Committee in order to set and execute traditional M&A, partnership and investment strategies. The group facilitates the Company's long range planning process by guiding each function through the process, developing key questions to be answered each year and providing quality control in advance of plan approval by leadership. Business intelligence and insights is a natural addition to these responsibilities.
About the Role The Corporate Development Director is responsible for supporting the Corporate Development function for Guardant Health. The role will be integral in all group functional capacities and requires a self-starter familiar with the capital markets, strategy, valuation, and financial analysis. An ability to understand the basics of genomics is helpful to succeed. The candidate will help proactively shape Guardant's corporate development strategy to help by identifying industry trends, maintaining relationships with relevant external partners, as well as sourcing, negotiating, structuring, and executing strategic acquisitions/investments across all of the Company's geographies and businesses. The role will assist and, in many cases, lead the development of new business models to help transform the enterprise as needed. This role will require extreme competency and adaptability as group priorities change in response to the ever-changing competitive environment for M&A. Even the planning process will be different each year as new key questions arise. This role is for those interested in a dynamic industry in its infancy and helping make Guardant the most successful competitor for many years.
Essential Duties and Responsibilities: Lead the transaction due diligence processDevelop business cases supported by market, valuation and financial analyticsSupport the Company's growth strategy through identification, assessment and execution of potential M&A, investments and partnerships.Support a robust and comprehensive process to identify and evaluate potential opportunities, which includes a rigorous idea generation and screening process that will bring quality acquisition and investment ideas to the Company's executive management teamCollaborate with leaders to think about corporate development opportunities in a progressive, systematic and routine fashion. Build relationships with each business unit to keep an ongoing flow of ideas that is aligned with business units' objectivesPartner with business leaders before, during and after the M&A processes to ensure the deals make strategic sense, fit with forward-looking business plans, and are integrated smoothly and fully optimizedSupport cross-functional teams in developing acquisition business case analyses and executing and interfacing with Finance, Accounting, Legal, Tax, HR and other departments of the Company to ensure seamless due diligence and deal executionQualificationsEssential Qualifications: 10+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank. Experience in Product, R&D, or Marketing a plusUndergraduate business degree, MBA or PhD degree with a technical background in genomics, therapeutics, or oncology preferredM&A partnering and equity investment experience, including some negotiation, thorough execution, and transaction closingIntermediate or advanced understanding of the biotech, diagnostic, or medical device industrySuperior analytical and problem-solving skillsAbility to structure and manage complex projects and processes with multiple stakeholders at all levels, including Executive and senior levelsExcellent presentation skills, including strong oral and writing capabilities and the ability to clearly communicate compelling messages to the Executive teamAbility to travel, both domestically and internationally, 10% - 20% to conferences and meetings
#J-18808-Ljbffr